{"nct_id":"NCT01669070","title":"A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI)","status":"COMPLETED","status_verified_date":"2017-06","start_date":"2012-08-15","start_date_type":"ACTUAL","primary_completion_date":"2012-11-16","primary_completion_date_type":"ACTUAL","completion_date":"2012-11-16","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}